Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -128.95% is 193% below its 5-year average of -43.97%, near the low end of its 5-year range (-128.95%–8.31%).
As of the fiscal period ended Tuesday, June 30, 2026. 36.19% below its 12-month average of -94.69%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -128.95%.
RETURN ON INVESTED CAPITAL (ROIC)
-128.95%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-94.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-59.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-43.97%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-35.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-18.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-17.86%
CURRENT VS TTM AVG
-36.19%
CURRENT VS 3Y AVG
-116.02%
CURRENT VS 5Y AVG
-193.29%
CURRENT VS 10Y AVG
-260.31%
CURRENT VS 15Y AVG
-586.21%
CURRENT VS 20Y AVG
-622.11%
SECTOR MEDIAN · HEALTHCARE
-33.80%
median of 696 covered companies
CURRENT VS SECTOR MEDIAN
-281.52%
vs the sector median at left
IM Cannabis Corp.
Market Cap
$1.14M
Return on Invested Capital (ROIC)
-128.95%
TTM Avg
-94.69%
3Y Avg
-59.70%
5Y Avg
-43.97%
Market Cap
$1.15M
Return on Invested Capital (ROIC)
-709.40%
TTM Avg
-164.13%
3Y Avg
-164.13%
5Y Avg
-164.13%
Market Cap
$1.16M
Return on Invested Capital (ROIC)
-183.49%
TTM Avg
-279.63%
3Y Avg
-279.63%
5Y Avg
-279.63%
Market Cap
$1.10M
Return on Invested Capital (ROIC)
-9.45%
TTM Avg
-4.19%
3Y Avg
5.39%
5Y Avg
5.39%
Market Cap
$1.08M
Return on Invested Capital (ROIC)
-60.41%
TTM Avg
-162.02%
3Y Avg
-321.37%
5Y Avg
-223.75%
Market Cap
$1.03M
Return on Invested Capital (ROIC)
-59.81%
TTM Avg
-3.58%
3Y Avg
-5.96%
5Y Avg
-5.96%
Market Cap
$1.39M
Return on Invested Capital (ROIC)
-107.08%
TTM Avg
-750.62%
3Y Avg
-506.81%
5Y Avg
-355.90%
Market Cap
$1.39M
Return on Invested Capital (ROIC)
-219.36%
TTM Avg
-214.97%
3Y Avg
-160.97%
5Y Avg
-133.06%
Market Cap
$1.39M
Return on Invested Capital (ROIC)
-32.53%
TTM Avg
-171.99%
3Y Avg
-201.88%
5Y Avg
-239.63%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| IM Cannabis Corp. (IMCC) | $1.14M | -128.95% | -94.69% | -59.70% | -43.97% |
| Jupiter Neurosciences, Inc. (JUNS)vs › | $1.15M | -709.40% | -164.13% | -164.13% | -164.13% |
| Propanc Biopharma, Inc. (PPCB)vs › | $1.16M | -183.49% | -279.63% | -279.63% | -279.63% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | -9.45% | -4.19% | 5.39% | 5.39% |
| Clearmind Medicine Inc. (CMND)vs › | $1.08M | -60.41% | -162.02% | -321.37% | -223.75% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | -59.81% | -3.58% | -5.96% | -5.96% |
| Genprex, Inc. (GNPX)vs › | $1.39M | -107.08% | -750.62% | -506.81% | -355.90% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.39M | -219.36% | -214.97% | -160.97% | -133.06% |
| NewcelX Ltd. (NCEL)vs › | $1.39M | -32.53% | -171.99% | -201.88% | -239.63% |
| Bone Biologics Corporation (BBLG)vs › | $873327.00 | -78.01% | -90.63% | -141.82% | -116.81% |
ROIC
-129.0%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -128.95% |
| 2026-03-31 | -91.26% |
| 2025-12-31 | -56.10% |
| 2025-09-30 | -106.96% |
| 2025-06-30 | -90.16% |
| 2025-03-31 | -81.14% |
| 2024-12-31 | -101.22% |
| 2024-09-30 | -35.31% |
| 2024-06-30 | -27.26% |
| 2024-03-31 | -30.42% |
| 2023-12-31 | 8.31% |
| 2023-09-30 | -8.82% |
| 2023-06-30 | -26.76% |
| 2023-03-31 | -47.45% |
| 2022-12-31 | -34.46% |
| 2022-09-30 | -17.44% |
| 2022-06-30 | -6.21% |
| 2022-03-31 | -7.71% |
| 2021-12-31 | -12.00% |
| 2021-09-30 | -10.97% |
| 2021-06-30 | -11.02% |
| 2021-03-31 | -7.89% |
| 2020-12-31 | -25.74% |
| 2020-09-30 | -12.76% |
| 2020-06-30 | -18.19% |
| 2013-01-31 | -3.48% |
| 2012-10-31 | -3.52% |
| 2012-07-31 | -4.06% |
| 2012-04-30 | -5.46% |
| 2012-01-31 | -6.77% |
| 2011-10-31 | -7.10% |
| 2011-07-31 | -7.65% |
| 2011-04-30 | -6.68% |
| 2011-01-31 | -7.91% |
| 2010-10-31 | -13.77% |
| 2010-07-31 | -12.84% |
| 2010-04-30 | -13.04% |
| 2010-01-31 | -14.73% |
| 2009-10-31 | -14.19% |
| 2009-07-31 | -12.95% |
| 2009-04-30 | -27.98% |
| 2009-01-31 | -25.13% |
| 2008-10-31 | -26.94% |
| 2008-07-31 | -22.23% |
| 2008-04-30 | -15.73% |
| 2008-01-31 | -24.75% |
| 2007-10-31 | -30.94% |
| 2007-07-31 | -34.65% |
| 2007-04-30 | -37.17% |
| 2007-01-31 | -98.84% |
| 2006-10-31 | -86.08% |
| 2006-07-31 | -78.62% |
| 2006-04-30 | -93.22% |
| 2006-01-31 | -65.96% |
| 2005-10-31 | -39.56% |
| 2005-07-31 | -38.39% |
| 2005-04-30 | -40.61% |
| 2005-01-31 | -37.74% |
| 2004-10-31 | -79.82% |
| 2004-07-31 | -142.19% |
| 2004-04-30 | -132.21% |
| 2004-01-31 | -117.86% |
| 2003-10-31 | -27.46% |
| 2003-07-31 | -197.52% |
